Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance. - Wikidata - awgldk - TriplyDB

Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance.

Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance.

http://www.wikidata.org/entity/Q35910243

about

The Complex Roles of Mechanistic Target of Rapamycin in Adipocytes and Beyond.Non-invasive metabolic imaging of brain tumours in the era of precision medicine.RICTOR polymorphisms affect efficiency of platinum-based chemotherapy in Chinese non-small-cell lung cancer patients.Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma.Cancer metabolism as a central driving force of glioma pathogenesis mTORC2 activity in brain cancer: Extracellular nutrients are required to maintain oncogenic signaling.The rate of glycolysis quantitatively mediates specific histone acetylation sites mTORC2 and Metabolic Reprogramming in GBM: at the Interface of Genetics and Environment.Clinical development of cancer therapeutics that target metabolism.Effects of Metformin and a Mammalian Target of Rapamycin (mTOR) ATP-Competitive Inhibitor on Targeted Metabolomics in Pancreatic Cancer Cell Line.Defective phosphoinositide metabolism in autism.Metabolic control of epigenetics in cancer.mTORC2 Responds to Glutamine Catabolite Levels to Modulate the Hexosamine Biosynthesis Enzyme GFAT1 Integrin-α10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade Myxofibrosarcoma.Inhibition of mTORC2 component RICTOR impairs tumor growth in pancreatic cancer models.mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT.Outside-in HLA class I signaling regulates ICAM-1 clustering and endothelial cell-monocyte interactions via mTOR in transplant antibody-mediated rejection.Molecular and Genetic Determinants of Glioma Cell Invasion.Cell surface GRP78 promotes tumor cell histone acetylation through metabolic reprogramming: a mechanism which modulates the Warburg effect.Purine synthesis promotes maintenance of brain tumor initiating cells in glioma.Tumor targeted delivery of doxorubicin in malignant peripheral nerve sheath tumors.Exon 3 mutations of CTNNB1 drive tumorigenesis: a review.Elevated TERT Expression in TERT-Wildtype Adult Diffuse Gliomas: Histological Evaluation with a Novel TERT-Specific Antibody.

P2860

Q30235555-0C402D50-FA0E-421A-BF0A-0D75D0158C81 Q31115540-6D74D90E-7646-4570-931B-D5512618E20E Q33435610-9571E14E-639E-4487-A591-C42F6CD99136 Q33615797-778ED9F3-851B-4EBD-A2F9-ACA8DA485A06 Q33847616-B39A6259-3F88-4730-AC31-9B428F94510F Q33884658-EA707D87-9D60-43AB-AB9B-7B2D5AA5BB9F Q36084910-C3CA24AC-CC67-4F93-B614-F1D705E2126D Q36256815-7B41F252-BF33-405B-A592-55C0EE062109 Q36988292-D0A90B0F-F8F4-42D4-9D86-9EDB57A4BC7D Q38715697-4AA7BC2C-C7A3-47DE-BFD3-8407D7A4AB25 Q38885442-54463556-F025-4F49-8BDD-1F2CA7BFDC9E Q38955875-D7E19B90-0E8C-4269-9A55-730231592240 Q40982617-C983BD85-FED8-4AE2-B462-5CCC8708C354 Q41636388-3FDC9E43-E277-4A1B-8216-E31494AA1554 Q41781449-F2B967AD-D449-444D-BC88-7117606E8511 Q46197917-CEB65DF4-7092-40D0-AD05-6162D13A36A9 Q46258296-49B01D85-E1F9-4768-911F-E9EA6DF8CCC3 Q46594099-E6912762-280C-47EA-8795-E4DB4F263BC9 Q47096429-59BEBF11-32D8-4202-B901-8FABA35EA67E Q47566392-E0A28494-4045-4704-A00C-EEF47BCB98E4 Q48303412-1CF7AA90-ECD6-40F9-AE6B-B06D1AF45942 Q49427525-7F0C33F7-6315-4733-943E-9161744AA451 Q52564490-89F36662-EF05-4CDC-9B52-C2ACED330560

P2860

Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance.

http://www.wikidata.org/entity/Q35910243

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance.

@ast

Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance.

@en

type

label

Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance.

@ast

Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance.

@en

prefLabel

Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance.

@ast

Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance.

@en

P1433

Q35910243-FBF9CA70-79C2-47FD-B244-8A54CCD6AC0C

P1476

Q35910243-D50DBD04-1BD3-490F-B1E8-280A3E083F24

P2093

Q35910243-22D63998-E4EE-46FD-A744-69D683E6AFEF

Q35910243-3152E0F7-C529-4003-B459-AD17FC8CAC5B

Q35910243-319B75B5-0E2B-4BF5-B7A3-436A8B23BBE9

Q35910243-4E385632-A3EC-4156-8010-10EA0D9F6C14

Q35910243-54185B43-32F6-418C-A355-556A74BD7BCD

Q35910243-A3D7D44B-D82B-41DE-8ACB-F84DD863169B

Q35910243-AB055914-406B-499D-9CB8-04028E881755

Q35910243-BD9318A2-B458-4602-92C3-674DD499A964

Q35910243-D49194EE-5D84-4CBF-9CD7-4A18467FBD98

Q35910243-EDC3880C-0D93-4B8C-BB2F-24BB6CD8472B

P2860

Q35910243-026D1BD2-6324-43E9-B2F4-B27EC319DFD9

Q35910243-0C751401-2C57-411C-932E-5476F548892F

Q35910243-1DBB11EC-B006-44B7-B843-F4AA2593672B

Q35910243-1EB0492A-B8AB-4451-89CA-917F4D658595

Q35910243-1F8891AF-5D0F-4DAF-B8F4-5D313CFB3093

Q35910243-20275C40-E153-4C7D-A9D6-8B289693243B

Q35910243-238434B4-9D7B-4718-86C1-A6D8713D870C

Q35910243-35E3D720-F8F8-48FF-9509-5836A1A5462B

Q35910243-35EE2324-F504-468C-A4F2-A38D9C0C5378

Q35910243-387030B6-23CD-449D-8A9F-380B550C4FBB

P304

Q35910243-F6C0D914-420A-4EE8-9093-B4837C0D63A9

P31

Q35910243-566E20C8-EC68-4D5A-96B7-97F4DD5638C3

P356

Q35910243-9A18E6A7-638E-43ED-AD69-5C4050303A4F

P407

Q35910243-DB79A99E-DF88-4127-B9B3-08C259CCD162

P433

Q35910243-AA98C006-E95E-4BBF-ABDC-C54CE499E74E

P478

Q35910243-3A0542BF-8831-4B9C-8A5B-0077C226FB3C

P577

Q35910243-EC444D8C-A1BC-4CBD-9D00-244223349B07

P5875

Q35910243-16E979F6-47A5-48BE-B898-D4E7FC47B44C

P698

Q35910243-66AEF60B-87F4-4263-9C7E-F70EE8F9F390

P932

Q35910243-DE9CDCD5-782A-4BD1-B6B3-E718AF22CC40

P356

PNAS.1511759112

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance.

@en

P2093

Genaro R Villa

http://www.w3.org/2001/XMLSchema#string

Huijun Yang

http://www.w3.org/2001/XMLSchema#string

Kanato Yamagata

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Tanaka

http://www.w3.org/2001/XMLSchema#string

Kenta Masui

http://www.w3.org/2001/XMLSchema#string

Nobutaka Arai

http://www.w3.org/2001/XMLSchema#string

Paul S Mischel

http://www.w3.org/2001/XMLSchema#string

Shiro Ikegami

http://www.w3.org/2001/XMLSchema#string

Timothy F Cloughesy

http://www.w3.org/2001/XMLSchema#string

Webster K Cavenee

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Regulation of cellular metabolism by protein lysine acetylation

Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5

Understanding the Warburg effect: the metabolic requirements of cell proliferation

Links between metabolism and cancer

mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice

What a tangled web we weave: emerging resistance mechanisms to inhibition of the phosphoinositide 3-kinase pathway

Lysine acetylation targets protein complexes and co-regulates major cellular functions

ATP-citrate lyase links cellular metabolism to histone acetylation

Metabolic reprogramming: a cancer hallmark even warburg did not anticipate

P304

9406-9411

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1511759112

http://www.w3.org/2001/XMLSchema#string

P407

P433

30

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281801515

http://www.w3.org/2001/XMLSchema#string

P698

26170313

http://www.w3.org/2001/XMLSchema#string

P932

4522814

http://www.w3.org/2001/XMLSchema#string